Number | Date | Country | Kind |
---|---|---|---|
9502051 | Feb 1995 | GBX | |
9510254 | May 1995 | GBX |
This application is a 371 of PCT/EP96/00369 filed Jan. 24, 1996.
Filing Document | Filing Date | Country | Kind | 102e Date | 371c Date |
---|---|---|---|---|---|
PCT/EP96/00369 | 1/24/1996 | 9/16/1997 | 9/16/1997 |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO96/23769 | 8/8/1996 |
Number | Name | Date | Kind |
---|---|---|---|
4428881 | Hedrich et al. | Jan 1984 | |
5322951 | King et al. | Jun 1994 |
Number | Date | Country |
---|---|---|
WO 9404533 | Mar 1994 | WOX |
WO 9414801 | Jul 1994 | WOX |
WO 9422871 | Oct 1994 | WOX |
WO 9501976 | Jan 1995 | WOX |
WO 95 21844 | Aug 1995 | WOX |
WO 9529177 | Nov 1995 | WOX |
WO 9602637 | Feb 1996 | WOX |
Entry |
---|
I.T. Forbes, "5-Methyl-1-(3-pyridylcarbamoyl)-1,2.3.5-tetrahydropyrrolo[2,3-f]indole: A Novel 5 HT.sub.2C /5-HT.sub.2B Receptor Antagonist with Improved Affinity, Selectivity, and Oral Activity", (1995), J. Med. Chem., 38(14), pp. 2524-2530. |